ProPhase Labs, Inc. Goodwill, Acquired During Period
ProPhase Labs, Inc. (PRPH) reported Goodwill, Acquired During Period of $4.45 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-29.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2023-03-29
- ProPhase Labs, Inc. goodwill, acquired during period for the quarter ending 2021-12-31 was $3.96M.
- ProPhase Labs, Inc. goodwill, acquired during period for fiscal 2021 was $4.45M, a 393.45% increase from fiscal 2020.
- ProPhase Labs, Inc. goodwill, acquired during period for fiscal 2020 was $901.00K.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|
| 2021-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $4.45M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $484.00K 10-Q · filed 2021-11-12 | ||
| 2020-12-31 | $901.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |